New therapeutic target found for aggressive pediatric cancers with few treatment options

Researchers at the University of Texas MD Anderson Cancer Center recently discovered a new therapeutic target for malignant rhabdoid tumors (MRT). MRT is a rare pediatric cancer that commonly starts in the kidneys. Dr. Pavlos Msaouel, who was a 2017 Conquer Cancer Foundation Young Investigator Award recipient supported by the Kidney Cancer Association, was involved in this breakthrough finding.02/19/2019
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news